Listed

Amneal Pharmaceuticals, Inc.: Form 10-K for the period ended Dec 31, 2017

Filed with the SEC on Mar 9, 2018 and accepted by EDGAR at Mar 9, 2018, 17:00 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Income tax3 months2017-10-04 to 2017-12-31$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-10-05 to 2017-12-31$0us-gaap:NetIncomeLoss
Operating cash flow3 months2017-10-05 to 2017-12-31$0us-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2017-12-31$0us-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-12-31$0us-gaap:AssetsCurrent
Total assetsAt period end2017-12-31$0us-gaap:Assets
Current liabilitiesAt period end2017-12-31$0us-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-12-31$0us-gaap:Liabilities
Shareholders' equityAt period end2017-12-31$0us-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001723128-18-000005. Last ingested by Listed: Nov 10, 2026, 02:45 ET. Listed shows no prices and gives no investment advice.